Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
| Status: | Completed |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/1/2019 |
| Start Date: | November 2015 |
| End Date: | November 2016 |
To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard
HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port
protector.
HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port
protector.
Prospective, cluster-randomized, open-label, post market, comparative effectiveness
evaluation with facilities participating for up to 13 months.
evaluation with facilities participating for up to 13 months.
Inclusion Criteria:
- All patients dialyzing with a central venous catheter
Exclusion Criteria:
- Known allergy to chlorhexidine
We found this trial at
1
site
Click here to add this to my saved trials
